FloridaMarijuana.net

AUGUST 15, 2018

A January 2018 Scientific American article titled “As Vets Demand Cannabis for PTSD, Science Races to Unlock Its Secrets” details a 2009 clinical trial in Canada which showed that the nighttime administration of THC reduced the frequency and intensity of nightmares in 72 percent of the 47 patients studied.”.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

CannaMD

NOVEMBER 8, 2019

At present, most products containing THC, CBD, or other cannabinoids are not approved for this purpose by the FDA. In fact, we know very well that people with PTSD who use marijuana — a potent cannabinoid — often experience more relief from their symptoms than they do from antidepressants and other psychiatric medications.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

The Cannigma

JULY 1, 2022

Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JUNE 11, 2019

A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. A pain management specialist recommended a trial of Nabilone, the synthetic cannabinoid, or of medical marijuana. I decline to award a sum of money to permit the plaintiff to experiment with cannabinoids; … 23.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

NOVEMBER 24, 2021

The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). These were news stories focusing on the use of cannabinoids for chronic cancer pain or inhibiting tumour growth, and mental illness. 2016 ; Sznitman et al. Discussion.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

We support the Hemp Roundtable’s statements on psychoactive hemp and that it should be regulated separately from hemp, CBD, CBG and other non-psychoactive or non-intoxicating cannabinoids. Born and raised in San Diego, Dave attended San Diego State University in 2009 where he received his bachelor’s degree in chemistry.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105